Clinical Trials Sponsored by Iroko Pharmaceuticals, LLC

Total 620 results

Sebela Pharmaceuticals Development LLC

Completed

Safety and Efficacy Study of an Edible Colonoscopy Preparation

Colon Prep for Colonoscopy

United States
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Long-Term Safety Evaluation Of Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Constipation | Bowel Dysfunction

United States, Taiwan, Australia, Canada, Hungary, Spain, Finland, United Kingdom, Hong Kong, Sweden, Austria, Denmark, Poland, Netherlands, New Zealand, Ireland, Switzerland
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

Ileus

United States
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects

Cancer | Bowel Dysfunction

United States, France, Canada, Finland, Spain, Pakistan, Poland, Hong Kong, United Kingdom, Peru, New Zealand, Portugal, Russian Federation
Pharmacyclics LLC.
Janssen Pharmaceuticals

Completed

Safety and Efficacy of PCI-32765 in Participants With Relapsed/Refractory Mantle Cell Lymphoma (MCL) (PCYC-1104-CA)

Mantle Cell Lymphoma

United States, United Kingdom, Germany, Poland
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Clinical Outcomes After Bowel Resection in Patients Receiving Alvimopan Versus Patients Not Receiving Alvimopan in the Premier Perspective Database

Ileus

United States
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus

Ileus

United States
AmDerma
AmDerma Pharmaceuticals, LLC

Completed

Safety and Efficacy of Econazole Nitrate Foam 1% and Foam Vehicle in Subjects With Tinea Pedis

Tinea Pedis | Athlete's Foot

United States
High Point Pharmaceuticals, LLC.

Terminated

Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease

Mild Cognitive Impairment | Mild Alzheimer's Disease

United States
OnQuality Pharmaceuticals (USA) LLC

Active, not recruiting

A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients (NOVA-II)

Hand-Foot Skin Reaction (HFSR)

United States, China, India
Castle Creek Pharmaceuticals, LLC

Completed

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Dystrophic Epidermolysis Bullosa | Epidermolysis Bullosa Simplex | Junctional Epidermolysis Bullosa | Epidermolysis Bullosa (EB)

United States
Alopexx Pharmaceuticals, LLC

Terminated

Trial to Assess the Efficacy of F598 in Preventing an Experimental Urethral Infection With N. Gonorrhoeae in Healthy Males

Neisseria Gonorrhoeae

United States
High Point Pharmaceuticals, LLC.

Terminated

A Safety and Efficacy Study of HPP404 on Weight Loss in Overweight or Obese Subjects

Obesity | Overweight

United States
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Treatment Of Constipation Due To Opioids Being Taken For Persistent Non-Cancer Pain

Constipation | Bowel Dysfunction

United States, Germany, Estonia, Finland, United Kingdom, Canada, Austria, Denmark, Poland, Ireland
Cubist Pharmaceuticals LLC
Pfizer

Terminated

Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia

Postherpetic Neuralgia

United States
Cubist Pharmaceuticals LLC
GlaxoSmithKline

Completed

Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/ Postoperative Ileus

Ileus

United States
AmDerma
AmDerma Pharmaceuticals, LLC

Completed

Comparative PK Study of Econazole Nitrate Foam and Econazole Nitrate Cream in Subjects With Interdigital Tinea Pedis Aged 12 Years to Less Than 18 Years

Interdigital Tinea Pedis

United States
Kira Pharmacenticals (US), LLC.

Not yet recruiting

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104

Paroxysmal Nocturnal Hemoglobinuria

China
Kira Pharmacenticals (US), LLC.

Not yet recruiting

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Glomerulonephritis
GU Research Network, LLC
Churchill Pharmaceutical LLC

Completed

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

Prostate Cancer

United States
Kira Pharmacenticals (US), LLC.

Not yet recruiting

Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Kira Pharmacenticals (US), LLC.

Completed

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Paroxysmal Nocturnal Hemoglobinuria

Australia
Osmotica Pharmaceutical US LLC

Completed

Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease

Parkinson's Disease

Argentina
HealthPartners Institute
Amylin Pharmaceuticals, LLC.

Completed

Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide

Type 2 Diabetes Mellitus

United States
Alexion Pharmaceuticals, Inc.
Xcenda, LLC

Active, not recruiting

Patient Reported Outcomes in Adults With Pediatric-onset Hypophosphatasia Treated With Strensiq® (Asfotase Alfa)

Hypophosphatasia

United States
Promomed, LLC
Solyur Pharmaceuticals Group

Completed

Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19

COVID-19

Russian Federation
Hartford Hospital
Cubist Pharmaceuticals LLC

Completed

Entereg Laparoscopic Colon Resection Study

Laparoscopic Colonic Resection

United States
Cubist Pharmaceuticals LLC
Syneos Health

Terminated

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment

Renal Impairment

United States
Duke University
Cubist Pharmaceuticals LLC

Terminated

A Pilot Study of Daptomycin for Antimicrobial Prophylaxis

Antimicrobial Prophylaxis

United States
JHP Pharmaceuticals LLC
Syneos Health

Unknown

Equivalence Study of Specificity of PPD (03)

Tuberculosis Infection

United States
Yale University
Amylin Pharmaceuticals, LLC.

Withdrawn

The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

Obesity | Cardiovascular Disease | Insulin Resistance | Impaired Glucose Tolerance
Hikma Pharmaceuticals LLC
Winterlight Labs

Completed

Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With Schizophrenia

Schizophrenia

Algeria, Egypt, Jordan, Saudi Arabia
Anelixis Therapeutics, LLC

Completed

Multiple Doses of AT-1501-A201 in Adults With ALS

Amyotrophic Lateral Sclerosis

United States, Canada
Anelixis Therapeutics, LLC

Withdrawn

Safety, Tolerability and Efficacy of Immunomodulation With AT-1501 in Islet Cell Transplantation

Type 1 Diabetes Mellitus

Canada
Tarix Pharmaceuticals
Constant Therapeutics LLC

Terminated

Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients (TXA127-PBSC)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease

United States
Tarix Pharmaceuticals
Constant Therapeutics LLC

Terminated

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation (USBTXA127CBT)

Myelofibrosis | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myelocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Hodgkins Lymphoma | Non Hodgkins Lymphoma | Double Cord Blood Transplant

United States
Hikma Pharmaceuticals LLC
Syneos Health

Completed

Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan (PASSRRA)

Rheumatoid Arthritis

Jordan
Hartford Hospital
Optimer Pharmaceuticals LLC

Completed

Study to Assess Inhibition of Spore Production in Patients With C. Difficile Infections: Fidaxomicin Versus Vancomycin

Clostridium Difficile Infection

United States
HealthPartners Institute
Amylin Pharmaceuticals, LLC.

Completed

Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control

Type 2 Diabetes

United States
Asklepion Pharmaceuticals, LLC
Vanderbilt University

Completed

Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery

Hypertension, Pulmonary | Heart Defects, Congenital

United States
JHP Pharmaceuticals LLC
Syneos Health

Unknown

Equivalence Study of Tuberculin Purified Protein Derivative in Comparison With a Reference Standard (PPD-S2) (02)

Tuberculosis Identification.
JHP Pharmaceuticals LLC
Syneos Health

Unknown

Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

Tuberculosis Infection

United States
SCRI Development Innovations, LLC
Novartis Pharmaceuticals; OSI Pharmaceuticals

Completed

Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
AbbVie
Endo Pharmaceuticals; Allergan Sales, LLC; Acerus Pharmaceuticals Corporation; Upsher-Smith...

Completed

A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men (TRAVERSE)

Cardiovascular Diseases | Hypogonadism

United States, Puerto Rico
Foresee Pharmaceuticals Co., Ltd.
QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Puberty; Precocious, Central

United States, China, Taiwan, Puerto Rico
Janssen Pharmaceutical K.K.
Pharmacyclics LLC.

Completed

A Study to Evaluate the Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Patients With Recurrent Mature B-Cell Neoplasms

Recurrent Mature B-cell Neoplasms

Japan
TLL Pharmaceutical, LLC

Withdrawn

Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis

Ulcerative Colitis

United States
SCRI Development Innovations, LLC
Millennium Pharmaceuticals, Inc.; Aventis Pharmaceuticals

Completed

Weekly Docetaxel and Bortezomib in the Treatment of Advanced Hormone-Refractory Prostate Cancer

Prostate Cancer
TLL Pharmaceutical, LLC

Completed

A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy Participants

Healthy

United States
University of Utah
AltaThera Pharmaceuticals, LLC

Completed

Prospective Evaluation Analysis and Kinetics Registry (PEAKS)

Atrial Arrhythmia

United States

Clinical Trials Sponsored by Iroko Pharmaceuticals, LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations